Pharmacodynamic variability is particularly challenging for insulin, due to the large absorption variability associated with oral dosing in combination with a narrow therapeutic window with an overdose being associated with potentially life-threatening hypoglycaemia. The gene discussed is INS; the disease is Hypoglycemia.